Abstract
Cholinergic neurons of the medial forebrain are considered important contributors to brain plasticity and neuromodulation. A reduction of cholinergic innervation can lead to pathophysiological changes of neurotransmission and is observed in Alzheimer’s disease. Here we report on six patients with mild to moderate Alzheimer’s disease (AD) treated with bilateral low-frequency deep brain stimulation (DBS) of the nucleus basalis of Meynert (NBM). During a four-week double-blind sham-controlled phase and a subsequent 11-month follow-up open label period, clinical outcome was assessed by neuropsychological examination using the Alzheimer’s Disease Assessment Scale—cognitive subscale as the primary outcome measure. Electroencephalography and [18F]-fluoro-desoxyglucose positron emission tomography were, besides others, secondary endpoints. On the basis of stable or improved primary outcome parameters twelve months after surgery, four of the six patients were considered responders. No severe or non-transitional side effects related to the stimulation were observed. Taking into account all limitations of a pilot study, we conclude that DBS of the NBM is both technically feasible and well tolerated.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Grothe M, Heinsen H, Teipel SJ . Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer's disease. Biol Psychiatry 2012; 71: 805–813.
Buzsaki G, Bickford RG, Ponomareff G, Thal LJ, Mandel R, Gage FH . Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci 1988; 8: 4007–4026.
Kilgard MP, Merzenich MM . Cortical map reorganization enabled by nucleus basalis activity. Science 1998; 279: 1714–1718.
Turnbull IM, McGeer PL, Beattie L, Pate B . Stimulation of the basal nucleus of Meynert in senile dementia of Alzheimer’s type. A preliminary report. Appl Neurophysiol 1985; 48: 216–221.
Freund HJ, Kuhn J, Lenartz D, Mai JK, Schnell T, Klosterkoetter J et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol 2009; 66: 781–785.
Barnikol TT, Pawelczyk NB, Barnikol UB, Kuhn J, Lenartz D, Sturm V et al. Changes in apraxia after deep brain stimulation of the nucleus basalis Meynert in a patient with Parkinson dementia syndrome. Mov Disord 2010; 25: 1519–1520.
Hamani C, McAndrews MP, Cohn M, Oh M, Zumsteg D, Shapiro CM et al. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol 2008; 63: 119–123.
Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer’s disease. Ann Neurol 2010; 68: 521–534.
Hardenacke K, Kuhn J, Lenartz D, Maarouf M, Mai JK, Bartsch C et al. Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer’s dementia. World Neurosurg 2012; 80: S27.e35–S27.e43.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-DSM IV-TR. American Psychiatric Association: Washington, DC, USA, 2000.
Bramer GR . International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q 1988; 41: 32–36.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34: 939–944.
Mai J, Paxinos G, Voss T . Atlas of the Human Brain, 3rd revised edn. Academic Press: Amsterdam, The Netherlands, 2007, p 271.
Grisso T, Appelbaum PS, Hill-Fotouhi C . The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv 1997; 48: 1415–1419.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 2013; 368: 610–622.
Mesulam MM, Mufson EJ, Levey AI, Wainer BH . Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 1983; 214: 170–197.
Pearson RC, Sofroniew MV, Cuello AC, Powell TP, Eckenstein F, Esiri MM et al. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer’s type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 1983; 289: 375–379.
Mesulam MM, Geula C . Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 1988; 275: 216–240.
Vogels OJ, Broere CA, ter Laak HJ, ten Donkelaar HJ, Nieuwenhuys R, Schulte BP . Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer’s disease. Neurobiol Aging 1990; 11: 3–13.
Higgins GA, Mufson EJ . NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer’s disease. Exp Neurol 1989; 106: 222–236.
Grothe M, Zaborszky L, Atienza M, Gil-Neciga E, Rodriguez-Romero R, Teipel SJ et al. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer’s disease. Cereb Cortex 2010; 20: 1685–1695.
Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer’s disease. J Comp Neurol 1999; 411: 693–704.
Benabid AL, Benazzous A, Pollak P . Mechanisms of deep brain stimulation. Mov Disord 2002; 17 (Suppl 3): S73–S74.
Kurosawa M, Sato A, Sato Y . Stimulation of the nucleus basalis of Meynert increases acetylcholine release in the cerebral cortex in rats. Neurosci Lett 1989; 98: 45–50.
Maier F, Lewis CJ, Horstkoetter N, Eggers C, Kalbe E, Maarouf M et al. Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson’s disease: a mixed-method approach. J Neurol Neurosurg Psychiatry 2013; 84: 1273–1281.
Rothi LJ, Heilman KM . Acquisition and retention of gestures by apraxic patients. Brain Cogn 1984; 3: 426–437.
Goldenberg G . Matching and imitation of hand and finger postures in patients with damage in the left or right hemispheres. Neuropsychologia 1999; 37: 559–566.
Guigoz Y, Vellas B, Garry PJ . Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996; 54 (1 Pt 2): S59–S65.
Brunovsky M, Matousek M, Edman A, Cervena K, Krajca V . Objective assessment of the degree of dementia by means of EEG. Neuropsychobiology 2003; 48: 19–26.
Schrag A, Schott JM . What is the clinically relevant change on the ADAS-Cog? J Neurol Neurosurg Psychiatry 2012; 83: 171–173.
Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C et al. Long-term progression of Alzheimer’s disease in patients under antidementia drugs. Alzheimers Dement 2011; 7: 579–592.
Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS et al. Longitudinal change of biomarkers in cognitive decline. Arch Neurol 2011; 68: 1257–1266.
Coben LA, Danziger W, Storandt M . A longitudinal EEG study of mild senile dementia of Alzheimer type: changes at 1 year and at 2.5 years. Electroencephalogr Clin Neurophysiol 1985; 61: 101–112.
Suthana N, Haneef Z, Stern J, Mukamel R, Behnke E, Knowlton B et al. Memory enhancement and deep-brain stimulation of the entorhinal area. N Engl J Med 2012; 366: 502–510.
Boix-Trelis N, Vale-Martinez A, Guillazo-Blanch G, Marti-Nicolovius M . Induction of c-Fos expression by electrical stimulation of the nucleus basalis magnocellularis. Neurosci Lett 2009; 449: 137–141.
Morres SA, Mai JK, Teckhaus L . Expression of the CD15 epitope in the human magnocellular basal forebrain system. Histochem J 1992; 24: 902–909.
Hotta H, Kagitani F, Kondo M, Uchida S . Basal forebrain stimulation induces NGF secretion in ipsilateral parietal cortex via nicotinic receptor activation in adult, but not aged rats. Neurosci Res 2009; 63: 122–128.
Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005; 11: 551–555.
Acknowledgements
This study was supported by grants from the Marga and Walter Boll foundation and Medtronic Europe SARL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Jens Kuhn has occasionally received honoraria from AstraZeneca, Lilly, Lundbeck and Otsuka Pharma for lecturing at conferences and financial support to travel. He received financial support for studies from Medtronic Europe SARL (Meerbusch, Germany).
Doris Lenartz and Juergen K. Mai received financial assistance for travel to congresses from Medtronic Europe SARL. Mohammad Maarouf has occasionally received honoraria from Medtronic Europe SARL for lecturing at conferences and consulting. Volker Sturm disclosed financial support for studies and travel to congresses, and lecture fees from Medtronic Europe SARL and Advanced Neuromodulation Systems INC. He is also a co-holder of patents on desynchronized brain stimulation and shareholder of ANM-GmbH Juelich, a company that intends to develop new stimulators.
The remaining authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Rights and permissions
About this article
Cite this article
Kuhn, J., Hardenacke, K., Lenartz, D. et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia. Mol Psychiatry 20, 353–360 (2015). https://doi.org/10.1038/mp.2014.32
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2014.32
This article is cited by
-
Neuroprosthetics: from sensorimotor to cognitive disorders
Communications Biology (2023)
-
Non-invasive temporal interference electrical stimulation of the human hippocampus
Nature Neuroscience (2023)
-
An updated overview of recent and ongoing deep brain stimulation (DBS) trials in patients with dementia: a systematic review
Neurological Sciences (2023)
-
Parkinson Disease Dementia Management: an Update of Current Evidence and Future Directions
Current Treatment Options in Neurology (2023)
-
Deep brain stimulation of the nucleus basalis of Meynert modulates hippocampal–frontoparietal networks in patients with advanced Alzheimer’s disease
Translational Neurodegeneration (2022)